Form 3 Filing for Avadel Pharmaceuticals PLC

This filing reports the beneficial ownership of securities for Avadel Pharmaceuticals PLC. Weiss Asset Management LP and Andrew M. Weiss are identified as reporting owners, each holding a 10% or greater ownership. The filing indicates that Weiss Asset Management LP, through its general partner WAM GP LLC and manager Andrew Weiss, has investment control over the shares. Andrew Weiss disclaims beneficial ownership except to the extent of his pecuniary interest. The reported securities are Ordinary Shares, with 11,112,052 shares owned following the transaction. The ownership is indirect, as detailed in Footnote 1, which clarifies the relationship between the investment funds and the reporting individuals/entities.